Diversified Trust Co Raises Holdings in Colgate-Palmolive Company $CL

Diversified Trust Co lifted its holdings in Colgate-Palmolive Company (NYSE:CL) by 12.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 96,003 shares of the company’s stock after buying an additional 10,892 shares during the quarter. Diversified Trust Co’s holdings in Colgate-Palmolive were worth $7,674,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Grimes & Company Inc. boosted its position in shares of Colgate-Palmolive by 1.0% during the 2nd quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock worth $1,136,000 after purchasing an additional 118 shares in the last quarter. RFG Advisory LLC increased its holdings in shares of Colgate-Palmolive by 1.4% in the 2nd quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock valued at $839,000 after purchasing an additional 123 shares in the last quarter. Tiemann Investment Advisors LLC lifted its stake in shares of Colgate-Palmolive by 2.1% in the second quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock valued at $553,000 after purchasing an additional 125 shares during the period. Redhawk Wealth Advisors Inc. boosted its holdings in Colgate-Palmolive by 2.4% during the second quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company’s stock worth $497,000 after buying an additional 129 shares in the last quarter. Finally, Westside Investment Management Inc. grew its position in Colgate-Palmolive by 85.5% during the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after buying an additional 130 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.1%

Colgate-Palmolive stock opened at $79.65 on Tuesday. The stock has a 50-day moving average price of $78.52 and a 200 day moving average price of $82.53. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The stock has a market cap of $64.21 billion, a PE ratio of 22.31, a P/E/G ratio of 5.68 and a beta of 0.30. The company has a current ratio of 0.93, a quick ratio of 0.60 and a debt-to-equity ratio of 5.90.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.02. The company had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.17 billion. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The firm’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same period last year, the company earned $0.91 EPS. Equities research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Wednesday, January 21st. Colgate-Palmolive’s payout ratio is presently 58.26%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CL. Evercore ISI decreased their price target on Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating on the stock in a research note on Monday, November 3rd. Citigroup decreased their target price on Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating on the stock in a research report on Monday, November 3rd. Wells Fargo & Company dropped their price target on Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating for the company in a research report on Monday, November 3rd. Barclays decreased their price objective on shares of Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 4th. Finally, Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a report on Monday, November 3rd. Ten research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $88.81.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.